» Articles » PMID: 30499084

A Low GLP-1 Response Among Patients Treated for Acute Organophosphate and Carbamate Poisoning: a Comparative Cross-sectional Study from an Agrarian Region of Sri Lanka

Overview
Publisher Springer
Date 2018 Dec 1
PMID 30499084
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Higher incidence of diabetes along with increased use of pesticides is seen in Southeast Asia. Recent hypothesis postulated a link between acetylcholinesterase inhibitor insecticides and type 2 diabetes through the GLP-1 pathway. This study compares the GLP-1 response between groups with low and high red blood cell acetylcholinesterase (RBC-AChE) activity. A comparative cross-sectional study was conducted amongst patients who were within 3 months after an acute organophosphate or carbamate poisoning (acute group) and amongst vegetable farmers with low (chronic group) and high (control group) RBC-AChE activity. Acute (366 mU/μM Hb) and chronic (361 mU/μM Hb) groups had significantly lower RBC-AChE activity in comparison to the control (471 mU/μM Hb) group (P < 0.0001). Only the acute group, which has had atropine therapy, showed a significantly lower 120 min value in comparison to the control group (P = 0.0028). Also, the acute group had significantly low late (P = 0.0287) and total (P = 0.0358) responses of GLP-1 in comparison to the control group. The findings of the study allude towards attenuation of GLP-1 response amongst patients after acute organophosphate and carbamate poisoning. The possibility of an atropine-mediated attenuation of GLP-1 response was discussed.

Citing Articles

Selected Liver Markers in Predicting the Severity of Organophosphate and Carbamate Poisoning.

Senarathne R, Hettiaratchi U, Athiththan L, Peiris H, Sarathchandra C, Senanayake H J Environ Public Health. 2022; 2022:7826396.

PMID: 35755887 PMC: 9232371. DOI: 10.1155/2022/7826396.


Organophosphate pesticides and new-onset diabetes mellitus: From molecular mechanisms to a possible therapeutic perspective.

Chung Y, Hou Y, Wang I, Lu K, Yen T World J Diabetes. 2021; 12(11):1818-1831.

PMID: 34888010 PMC: 8613664. DOI: 10.4239/wjd.v12.i11.1818.


In vivo, ex vivo and in vitro evidence for atropine-mediated attenuation of glucagon-like peptide-1 secretion: findings from a systematic review.

Rathish D, Agampodi S, Jayasumana C Environ Sci Pollut Res Int. 2019; 26(29):29597-29605.

PMID: 31446595 DOI: 10.1007/s11356-019-06227-2.


Comparison of biochemical parameters among DPP4 inhibitor users and other oral hypoglycaemic drug users: a cross-sectional study from Anuradhapura, Sri Lanka.

Rathish D, Jayasumana C, Agampodi S J Health Popul Nutr. 2019; 38(1):3.

PMID: 30674350 PMC: 6343272. DOI: 10.1186/s41043-019-0160-x.

References
1.
Vale J . Toxicokinetic and toxicodynamic aspects of organophosphorus (OP) insecticide poisoning. Toxicol Lett. 1999; 102-103:649-52. DOI: 10.1016/s0378-4274(98)00277-x. View

2.
Worek F, Mast U, Kiderlen D, Diepold C, Eyer P . Improved determination of acetylcholinesterase activity in human whole blood. Clin Chim Acta. 1999; 288(1-2):73-90. DOI: 10.1016/s0009-8981(99)00144-8. View

3.
Vilsboll T, Krarup T, Deacon C, Madsbad S, Holst J . Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients. Diabetes. 2001; 50(3):609-13. DOI: 10.2337/diabetes.50.3.609. View

4.
Ahren B, Holst J . The cephalic insulin response to meal ingestion in humans is dependent on both cholinergic and noncholinergic mechanisms and is important for postprandial glycemia. Diabetes. 2001; 50(5):1030-8. DOI: 10.2337/diabetes.50.5.1030. View

5.
Anini Y, Hansotia T, Brubaker P . Muscarinic receptors control postprandial release of glucagon-like peptide-1: in vivo and in vitro studies in rats. Endocrinology. 2002; 143(6):2420-6. DOI: 10.1210/endo.143.6.8840. View